By Nicole Huberfeld The Pacific Legal Foundation seems unable to face its defeat before the Court in June. The PLF has filed a motion seeking leave to amend a complaint on behalf of a small…
By Nadia N. Sawicki In May 2011, Jennie Linn McCormack was charged with violating an Idaho law making it a felony for any woman to undergo an abortion in a manner not authorized by statute. The…
By Adriana Benedict Last week, Public Citizen published a Health GAP analysis entitled “Leaked TPP Investment Chapter Presents a Grave Threat to Access to Medicines,” in which Professor Brook Baker explains four ways in which…
By The Petrie-Flom Center “In Plain Sight: A Solution to a Fundamental Challenge in Human Research”Journal of Law, Medicine, and Ethics, Forthcoming (Lois Shepard and Margaret Foster Riley, UVA) From the abstract: The conflict of…
By The Petrie-Flom Center Tuesday, September 25, 2012Austin Hall, Classroom 111Harvard Law School 12-1:30PM If you’re going to be in Cambridge next week, please join us for a special off-the-record debate on American health…
By Suzanne M. Rivera, Ph.D. Of all the protections provided in the Common Rule to safeguard the rights and welfare of research participants, there’s one glaring omission: treatment of study-related injuries. Our current regulatory apparatus…
By Holly Fernandez Lynch Great new Perspectives piece by Lisa Harris out in NEJM on the need to recognize that conscience can compel action, not only refusals to provide certain types of care (including abortion). Elizabeth…
[posted on behalf of Judy Daar] Mishaps in assisted reproductive technologies (ART) breed public outcries and legislative hand-wringing. It is no wonder a 2011 San Diego-based ART debacle dubbed “an international baby-selling ring” caught the attention…
By Yoni Schenker In Glenn Cohen’s first post on this blog, he questioned whether Mitt Romney’s position on abortion was coherent with respect to the rape and incest exception, but did not question the self-defense…
By Patrick O’Leary Back in February, President Obama’s FY 2013 budget authorized $4.5 billion for the Food and Drug Administration (FDA), about $2 billion of which was to come from user fees, the fees paid…
